| 69 | 0 | 262 |
| 下载次数 | 被引频次 | 阅读次数 |
慢性伤口的临床管理常常受到细菌感染和生物膜形成的挑战。为解决这一问题,我们通过氨基化壳聚糖(amide-modified chitosan, AMCS)与氧化葡聚糖(oxidized dextran, ODex)之间的动态席夫碱交联,开发了一种可注射的水凝胶(AMCS@ODex)。该交联策略不仅改善了壳聚糖固有的局限性,如溶解性和力学性能较差,还赋予了水凝胶优异的剪切稀化行为。AMCS@ODex水凝胶对大肠杆菌和耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus,MRSA)均表现出抗菌活性,抗菌率分别为58%和73%。此外,它还能有效破坏已形成的MRSA生物膜,破坏率约为50%。至关重要的是,该水凝胶展现出优异的生物相容性,使L929成纤维细胞的存活率大于90%。AMCS@ODex水凝胶集良好的抗菌性能、理想的力学性能及高生物相容性为一体,在对抗细菌感染等生物医学应用中前景广阔。
Abstract:The clinical management of chronic wounds is frequently challenged by bacterial infection and biofilm formation. To address this, we developed an injectable hydrogel, denoted as AMCS@ODex, via dynamic Schiff base bonding between amide-modified chitosan(AMCS) and oxidized dextran(ODex). This crosslinking strategy not only mitigated the inherent limitations of chitosan, such as poor solubility and mechanical properties, but also endowed the hydrogel with excellent shear-thinning behaviors. AMCS@ODex exhibited antibacterial efficacy against Escherichia coli(E. coli) and methicillin-resistant Staphylococcus aureus(MRSA), and the antibacterial rates against E.coli and MRSA were 58% and 73%, respectively. Furthermore, it effectively disrupted pre-formed MRSA biofilms, leading to a disruption rate approximately 50%. Critically, the hydrogel exhibited outstanding biocompatibility, supporting over 90% viability of L929 fibroblast cells. By integrating good antibacterial performance, with desirable mechanical properties and high biocompatibility, the AMCS@ODex hydrogel presents potential biomedical applications, particularly in the fight against bacterial infections.
[1]Miranda-Calderon L,Yus C,De Ganuza C R,et al.Combinatorial w ound dressings loaded w ith synergistic antibiotics in the treatment of chronic infected w ounds[J].Chemical Engineering Journal,2023,476:146679.
[2]Rˇaducu L,Moraru O E,Gheoca-Mutu D E,et al.Confronting a new challenge in plastic surgery:M DR infections in patients w ith chronic w ounds[J].Life,2024,14(4):444.
[3]Razdan K,Garcia-Lara J,Sinha V R,et al.Pharmaceutical strategies for the treatment of bacterial biofilms in chronic w ounds[J].Drug Discovery Today,2022,27(8):2137-2150.
[4]Paterson I K,Hoyle A,Ochoa G,et al.Optimising antibiotic usage to treat bacterial infections[J].Scientific Reports,2016,6:37853.
[5]Alaoui Mdarhri H,Benmessaoud R,Yacoubi H,et al.Alternatives therapeutic approaches to conventional antibiotics:advantages,limitations and potential application in medicine[J].Antibiotics,2022,11(12):1826.
[6]Gholap A D,Rojekar S,Kapare H S,et al.Chitosan scaffolds:expanding horizons in biomedical applications[J].Carbohydrate Polymers,2024,323:121394.
[7]Yan D Z,Li Y Z,Liu Y L,et al.Antimicrobial properties of chitosan and chitosan derivatives in the treatment of enteric infections[J].Molecules,2021,26(23):7136.
[8]Mirbagheri V S,Alishahi A,Ahmadian G,et al.Tow ard understanding the antibacterial mechanism of chitosan:experimental approach and in silico analysis[J].Food Hydrocolloids,2024,147:109382.
[9]Eickelpasch K,Lemke P,Sreekumar S,et al.Abioactivity matrix for antimicrobial activities of chitosans:a review[J].International Journal of Biological Macromolecules,2025,299:140740.
[10]Egorov A R,Kirichuk A A,Rubanik V V,et al.Chitosan and its derivatives:preparation and antibacterial properties[J].Materials,2023,16(18):6076.
[11]Xue T,Fang D J,Si L L,et al.Preparation of antibacterial and UV-protective cotton through coating w ith Ti O2-modified chitosan-based schiff bases[J].ACS Applied Polymer Materials,2024,6(14):8073-8083.
[12]Sikorski D,Bauer M,Frączyk J,et al.Antibacterial and antifungal properties of modified chitosan nonw ovens[J].Polymers,2022,14(9):1690.
[13]Katiyar J D,Halder A,Avais M,et al.Hydrophobic PEGylation of chitosan:a graft copolymer approach tow ard developing nontoxic antimicrobial chitosan[J].ACS Applied Polymer Materials,2023,5(12):9742-9750.
[14]Taokaew S,Kaewkong W,Kriangkrai W.Recent development of functional chitosan-based hydrogels for pharmaceutical and biomedical applications[J].G els,2023,9(4):277.
[15]Pirsa S,Khodaei S M,Karimi Sani I,et al.Hydrogels and biohydrogels:investigation of origin of production,production methods,and application[J].Polymer Bulletin,2023,80(10):10593-10632.
[16]Yan M Y,Wang L L,Wu Y Y,et al.Threedimensional highly porous hydrogel scaffold for neural circuit dissection and modulation[J].Acta Biomaterialia,2023,157:252-262.
[17]Peng J,Zhao H,Tu C Z,et al.In situ hydrogel dressing loaded w ith heparin and basic fibroblast grow th factor for accelerating w ound healing in rat[J].Materials Science and Engineering:C,2020,116:111169.
[18]Wang B,Fan L L,Cui Z L,et al.Liquid-metalloaded hydrogel w ith antibacterial effect and sustained release of grow th factor for w ound healing[J].Advanced Therapeutics,2024,7(6):2400056.
[19]Cui S N,Meng S,Liu Y,et al.Activating Ferroptosis of M 1 M acrophages:a novel mechanism of asiaticoside encapsuled in gelma for anti-inflammation in diabetic w ounds[J].Exploration,2025,5(6):20240062.
[20]Wei L Q,Liu X,Li Y Q,et al.Multifunctional PHC bandage for accelerated w ound healing in movable parts[J].Exploration,2025,5 (3),20230176.
[21]Ahmad U,Wan Hanaffi W N,Islam A,et al.Cutting edge strategies for diabetic w ound care:Nanotechnology,bioengineering,and beyond[J].BMEMat,2026,4(1):e70033.
[22]Liu N B,Zhu S J,Deng Y Z,et al.Construction of multifunctional hydrogel w ith metal-polyphenol capsules for infected full-thickness skin w ound healing[J].Bioactive Materials,2023,24:69-80.
[23]Bian S T,Ye H J,Wang P,et al.Antibacterial hydrogel:The sniper of chronic w ounds[J].BMEMat,2025,3(3):e12135.
基本信息:
DOI:10.19884/j.1672-5220.202510011
中图分类号:R318.08;TQ427.26
引用信息:
[1]王月月,伍思琴,罗金兰,等.具有可注射性及抗菌性能的动态交联水凝胶(英文)[J].Journal of Donghua University(English Edition),2026,43(03):23-31.DOI:10.19884/j.1672-5220.202510011.
基金信息:
National Natural Science Foundation of China (No. 81861138040); Natural Science Foundation of Shanghai City of China(No. 20ZR1401800)
2026-06-30
2026-06-30
2026-06-30